Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
07/29/2022* -- Results Q2 2022 -- 1.00 --
07/29/2022* 11:00 EST Earnings Call Q2 2022 -- -- --
04/29/2022 -- Results Q1 2022 1.03 0.92 11.96%
04/29/2022 11:00 EST Earnings Call Q1 2022 -- -- --
02/18/2022 -- Results Q4 2021 0.85 0.85 0.00%
02/18/2022 11:00 EST Earnings Call Q4 2021 -- -- --
10/29/2021 -- Results Q3 2021 0.92 0.94 -1.60%
10/29/2021 11:00 EST Earnings Call Q3 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 07/29/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 04/29/2022
Beat/Miss Upgrade
Return Since -2.18%
Last FQE 12/31/2021
Next FQE 03/31/2022

Profile

Edit
Balchem manufactures ingredients, nutrients, and chemicals for a wide variety of industries, including human nutrition, animal nutrition, and oil and gas. The company offers a wide variety of product lines, with some highly customized and others commodity-oriented. After the 2014 acquisition of SensoryEffects, the human nutrition and health segment now generates the largest share of companywide revenue and profits.
URL https://www.balchem.com
Investor Relations URL https://balchem.com/our-company/investor-relations
HQ State/Province New York
Sector Basic Materials
Industry Specialty Chemicals
Equity Style Small Cap/Blend
Next Earnings Release Jul. 29, 2022 (est.)
Last Earnings Release Apr. 29, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Dec. 27, 2021

Dividends

Dividend Per Share (TTM) 0.64
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.4007
Yield to Sector 0.1145
Yield to Industry 0.1976
Last Dividend Amt. 0.64
Dividend Frequency Annually
Last Ex-Dividend Date Dec. 27, 2021
Yield (TTM) 0.53%
Forward Yield 0.53%
Payout Ratio 19.48%
Cash Payout Ratio 15.21%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-8.27%
38.67%
-3.45%
-2.17%
30.38%
13.95%
46.89%
-28.52%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-17.67%
28.75%
27.73%
4.30%
-11.50%
69.43%
-11.05%
0.77%
13.70%
-53.73%
98.74%
-52.11%
-81.08%
-24.51%
735.4%
-11.42%
-13.72%
17.46%
20.39%
2.81%
57.67%
7.42%
38.82%
-6.89%
-27.41%
--
--
--
--
--
--
--
-81.02%
As of May 20, 2022.

Profile

Edit
Balchem manufactures ingredients, nutrients, and chemicals for a wide variety of industries, including human nutrition, animal nutrition, and oil and gas. The company offers a wide variety of product lines, with some highly customized and others commodity-oriented. After the 2014 acquisition of SensoryEffects, the human nutrition and health segment now generates the largest share of companywide revenue and profits.
URL https://www.balchem.com
Investor Relations URL https://balchem.com/our-company/investor-relations
HQ State/Province New York
Sector Basic Materials
Industry Specialty Chemicals
Equity Style Small Cap/Blend
Next Earnings Release Jul. 29, 2022 (est.)
Last Earnings Release Apr. 29, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Dec. 27, 2021

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
WIGRX 82.32M USD 2.33%
CCASX 88.53M USD 2.28%
NWKBX 29.53M USD 2.26%
WGMCX 42.07M USD 1.93%
SLYG 19.00M USD 0.96%
IJT 45.61M USD 0.94%
SLY 7.243M USD 0.44%
SPSM 18.11M USD 0.44%
VSMSX 18.72M USD 0.44%
IJR 269.93M USD 0.43%
VIOO 16.69M USD 0.43%
VTSIX 34.81M USD 0.42%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter BCPC Tweets